Drug updated on 1/4/2024
|Liquid (oral; 1.1 g/mL)
| Ongoing and
- For chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements.
Product Monograph / Prescribing Information
|Ravicti (glycerol phenylbutyrate) Prescribing Information.
|Horizon Therapeutics USA, Inc. Deerfield, IL
Clinical Practice Guidelines
|Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision.
|Journal of Inherited Metabolic Disease